IVERIC bio Inc $ 0.99 0.01 (1.02%)
Volume:
125
Avg Vol (1m):
76,905
Market Cap $:
40.73 Mil
Enterprise Value $:
-65,170,000.00
P/E (TTM):
0.60
P/B:
0.43
Manual of Stocks™ Web
Financial Strength | 5.4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 108.08 | ||
| Debt-to-Equity | 0.01 | ||
| Debt-to-EBITDA | -0.02 | ||
| Piotroski F-Score | 2 | ||
| Beneish M-Score | -3.83 | ||
| WACC vs ROIC | |||
Profitability | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| ROE % | 86.08 | ||
| ROA % | 46.76 | ||
| ROC (Joel Greenblatt) % | -8400.79 | ||
| 3-Year Revenue Growth Rate | -100 | ||
| 3-Year EBITDA Growth Rate | 20.9 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 0.6 | ||
| PE Ratio without NRI | 0.6 | ||
| Price-to-Owner-Earnings | 0.62 | ||
| PB Ratio | 0.43 | ||
| EV-to-EBIT | 1.02 | ||
| EV-to-EBITDA | 1.02 | ||
| Current Ratio | 9.31 | ||
| Quick Ratio | 9.31 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 0.4 | ||
| Price-to-Graham-Number | 0.11 | ||
| Earnings Yield (Greenblatt) % | 100.71 |